Eurofins Central Laboratory Expands US Lab Operations to PA Campus

Jul 07, 2014
By Applied Clinical Trials Editors

Eurofins Central Laboratory announced the expansion and relocation of its US Central Laboratory Operations to the company's 330,000 square foot Pharma Services campus in Lancaster, PA. The consolidation of the company's Central Laboratory with its Lancaster Laboratories comes amongst the recently announced acquisitions of US bioanalytical, discovery, genomic and diagnostic laboratories. The purpose built Central Laboratory is essential to the global footprint of wholly-owned laboratory facilities in the United States, Europe, Asia and China.

Read the full release here.


lorem ipsum